We’re improving your experience!

×

Starting April 21, you’ll be asked to log in or sign up for a free account after viewing 10 content pages each month.

Don’t worry—creating an account is quick and easy, and it comes with added benefits! Once logged in, you’ll not only continue accessing the content you already enjoy, but you’ll also unlock exclusive features like interactive donut plots for variant protein effects and variant impacts across the gene.

Stay tuned for these updates, and thank you for being part of our community!

Drug Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Drug Name Tislelizumab
Trade Name Tevimbra
Synonyms BGB-A317|tislelizumab-jsgr
Drug Descriptions

Tevimbra (tislelizumab) is a human monoclonal antibody that targets PD-1 (PDCD1), thereby blocking the binding of PD-L1 (CD274) and potentially resulting in activation of a T-cell immune response against tumor cells (PMID: 32769013, PMID: 32561638, PMID: 32540858). Tevimbra (tislelizumab) is FDA-approved for use in patients with unresectable or metastatic esophageal squamous cell carcinoma (FDA.gov).

DrugClasses Immune Checkpoint Inhibitor 149 PD-L1/PD-1 antibody 124
CAS Registry Number 1858168-59-8
NCIT ID C121775

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Allocetra-OTS + Tislelizumab Allocetra-OTS Tislelizumab 0 1
APL-1202 + Tislelizumab APL-1202 Tislelizumab 0 1
Bevacizumab + Capecitabine + LBL-007 + Tislelizumab Bevacizumab Capecitabine LBL-007 Tislelizumab 0 1
Bevacizumab + Fluorouracil + LBL-007 + Tislelizumab Bevacizumab Fluorouracil LBL-007 Tislelizumab 0 1
BG-C9074 + Tislelizumab BG-C9074 Tislelizumab 0 1
BGB-10188 + Tislelizumab BGB-10188 Tislelizumab 0 1
BGB-15025 + Tislelizumab BGB-15025 Tislelizumab 0 1
BGB-26808 + Tislelizumab BGB-26808 Tislelizumab 0 1
BGB-30813 + Tislelizumab BGB-30813 Tislelizumab 0 1
BGB-53038 + Tislelizumab BGB-53038 Tislelizumab 0 1
BGB-A3055 + Tislelizumab BGB-A3055 Tislelizumab 0 1
BGB-A425 + LBL-007 + Tislelizumab BGB-A425 LBL-007 Tislelizumab 0 1
BGB-A425 + Tislelizumab BGB-A425 Tislelizumab 0 2
BGB-A445 + Carboplatin + Tislelizumab BGB-A445 Carboplatin Tislelizumab 0 0
BGB-A445 + Cisplatin + Tislelizumab BGB-A445 Cisplatin Tislelizumab 0 0
BGB-A445 + Nab-paclitaxel + Tislelizumab BGB-A445 Nab-paclitaxel Tislelizumab 0 0
BGB-A445 + Paclitaxel + Tislelizumab BGB-A445 Paclitaxel Tislelizumab 0 0
BGB-A445 + Pemetrexed Disodium + Tislelizumab BGB-A445 Pemetrexed Disodium Tislelizumab 0 0
BGB-A445 + Tislelizumab BGB-A445 Tislelizumab 0 2
BGB-B167 + Tislelizumab BGB-B167 Tislelizumab 0 1
BGB-B2033 + Tislelizumab BGB-B2033 Tislelizumab 0 1
BGB-B3227 + Tislelizumab BGB-B3227 Tislelizumab 0 1
BGB-C354 + Tislelizumab BGB-C354 Tislelizumab 0 1
BGBA1217 + Capecitabine + Oxaliplatin + Tislelizumab BGBA1217 Capecitabine Oxaliplatin Tislelizumab 0 1
BGBA1217 + Capecitabine + Tislelizumab BGBA1217 Capecitabine Tislelizumab 0 1
BGBA1217 + Carboplatin + Etoposide + Tislelizumab BGBA1217 Carboplatin Etoposide Tislelizumab 0 1
BGBA1217 + Carboplatin + Nab-paclitaxel + Tislelizumab BGBA1217 Carboplatin Nab-paclitaxel Tislelizumab 0 1
BGBA1217 + Carboplatin + Paclitaxel + Tislelizumab BGBA1217 Carboplatin Paclitaxel Tislelizumab 0 1
BGBA1217 + Carboplatin + Pemetrexed Disodium + Tislelizumab BGBA1217 Carboplatin Pemetrexed Disodium Tislelizumab 0 1
BGBA1217 + Cisplatin + Etoposide + Tislelizumab BGBA1217 Cisplatin Etoposide Tislelizumab 0 1
BGBA1217 + Cisplatin + Fluorouracil + Tislelizumab BGBA1217 Cisplatin Fluorouracil Tislelizumab 0 1
BGBA1217 + Cisplatin + Paclitaxel + Tislelizumab BGBA1217 Cisplatin Paclitaxel Tislelizumab 0 1
BGBA1217 + Cisplatin + Pemetrexed Disodium + Tislelizumab BGBA1217 Cisplatin Pemetrexed Disodium Tislelizumab 0 1
BGBA1217 + Tislelizumab BGBA1217 Tislelizumab 0 6
Bria-OTS + Cyclophosphamide + Peginterferon alfa-2b + Tislelizumab Bria-OTS Cyclophosphamide Peginterferon alfa-2b Tislelizumab 0 0
Camrelizumab + Tislelizumab + Trastuzumab Camrelizumab Tislelizumab Trastuzumab 0 0
Canakinumab + Gemcitabine + Nab-paclitaxel + Tislelizumab Canakinumab Gemcitabine Nab-paclitaxel Tislelizumab 0 1
Capecitabine + Cisplatin + Tislelizumab Capecitabine Cisplatin Tislelizumab 0 0
Capecitabine + DKN-01 + Oxaliplatin + Tislelizumab Capecitabine DKN-01 Oxaliplatin Tislelizumab 0 1
Capecitabine + Oxaliplatin + Tislelizumab Capecitabine Oxaliplatin Tislelizumab 0 1
Capecitabine + Oxaliplatin + Tislelizumab + Zanidatamab Capecitabine Oxaliplatin Tislelizumab Zanidatamab 0 1
Capecitabine + Tislelizumab Capecitabine Tislelizumab 0 1
Carboplatin + Etoposide + lutetium Lu 177 dotatate + Tislelizumab Carboplatin Etoposide Tislelizumab lutetium Lu 177 dotatate 0 0
Carboplatin + Etoposide + Tislelizumab Carboplatin Etoposide Tislelizumab 0 0
Carboplatin + Gemcitabine + Tislelizumab Carboplatin Gemcitabine Tislelizumab 0 0
Carboplatin + LBL-007 + Tislelizumab Carboplatin LBL-007 Tislelizumab 0 0
Carboplatin + Nab-paclitaxel + Tislelizumab Carboplatin Nab-paclitaxel Tislelizumab 0 0
Carboplatin + Paclitaxel + Tislelizumab Carboplatin Paclitaxel Tislelizumab 0 2
Carboplatin + Pemetrexed Disodium + Tislelizumab Carboplatin Pemetrexed Disodium Tislelizumab 0 0
Cisplatin + Etoposide + Tislelizumab Cisplatin Etoposide Tislelizumab 0 1
Cisplatin + Fluorouracil + Tislelizumab Cisplatin Fluorouracil Tislelizumab 0 1
Cisplatin + Fluorouracil + Tislelizumab + Zanidatamab Cisplatin Fluorouracil Tislelizumab Zanidatamab 0 1
Cisplatin + Gemcitabine + Tislelizumab Cisplatin Gemcitabine Tislelizumab 0 1
Cisplatin + LBL-007 + Tislelizumab Cisplatin LBL-007 Tislelizumab 0 0
Cisplatin + Paclitaxel + Tislelizumab Cisplatin Paclitaxel Tislelizumab 0 0
Cisplatin + Pemetrexed Disodium + Tislelizumab Cisplatin Pemetrexed Disodium Tislelizumab 0 0
Crizotinib + Regorafenib + Tislelizumab Crizotinib Regorafenib Tislelizumab 0 0
Dacarbazine + Doxorubicin + Tislelizumab + Vinblastine Dacarbazine Doxorubicin Tislelizumab Vinblastine 0 1
DKN-01 + Tislelizumab DKN-01 Tislelizumab 0 1
Docetaxel + Tislelizumab Docetaxel Tislelizumab 0 1
Fluorouracil + Futibatinib + Leucovorin + Oxaliplatin + Tislelizumab Fluorouracil Futibatinib Leucovorin Oxaliplatin Tislelizumab 0 1
Fluorouracil + Hydroxyurea + Pamiparib + Tislelizumab Fluorouracil Hydroxyurea Pamiparib Tislelizumab 0 1
Fruquintinib + Tislelizumab Fruquintinib Tislelizumab 0 2
Garivulimab + Tislelizumab Garivulimab Tislelizumab 0 0
HFB200301 + Tislelizumab HFB200301 Tislelizumab 0 1
HFB200603 + Tislelizumab HFB200603 Tislelizumab 0 1
HRO761 + Tislelizumab HRO761 Tislelizumab 0 1
IMX-110 + Tislelizumab IMX-110 Tislelizumab 0 1
JDQ443 + Tislelizumab JDQ443 Tislelizumab 0 1
JDQ443 + Tislelizumab + TNO155 JDQ443 TNO155 Tislelizumab 0 1
KFA115 + Tislelizumab KFA115 Tislelizumab 0 0
LBL-007 + Paclitaxel + Tislelizumab LBL-007 Paclitaxel Tislelizumab 0 0
LBL-007 + Tislelizumab LBL-007 Tislelizumab 0 2
Nab-paclitaxel + Tislelizumab Nab-paclitaxel Tislelizumab 0 0
Niraparib + Tislelizumab Niraparib Tislelizumab 0 0
Pamiparib + Tislelizumab Pamiparib Tislelizumab 0 3
Pemetrexed Disodium + Tislelizumab Pemetrexed Disodium Tislelizumab 0 1
Sitravatinib + Tislelizumab Sitravatinib Tislelizumab 0 2
Surufatinib + Tislelizumab Surufatinib Tislelizumab 0 1
SX-682 + Tislelizumab SX-682 Tislelizumab 0 1
TetMYB + Tislelizumab TetMYB Tislelizumab 0 1
Tislelizumab Tislelizumab 0 26
Tislelizumab + Zanubrutinib Tislelizumab Zanubrutinib 0 1


Additional content available in Icon for CKB-BoostCKB BOOST